Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Ramamoorthy A, Pacanowski MA, Bull J, et al. Racial/ethnic differences in drug disposition and response: review of recently approved drugs. Clin Pharmacol Ther. 2015;97(3):263–73.
2. Smith Z, Botto E, Johnson O, et al. New benchmarks on demographic disparities in pivotal trials supporting FDA-Approved drugs and biologics. Ther Innov Regul Sci. 2023. https://doi.org/10.1007/s43441-023-00579-1.
3. IQVIA Institute for Human Data Science. Global Trends in R&D 2023: Activity, Productivity, and Enablers. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2023. 2023.
4. NDA regulations. 21 CFR 314.50 (d)(5). 1985.
5. U.S. Food and Drug Administration. Guidance for Industry. Collection of Race and Ethnicity Data in Clinical Trials. 2016.